Why 60 Degrees Pharmaceuticals, Inc. (SXTP) Went Down On Thursday?

We precocious published a database of 10 Stocks Fall Behind Amid Market Optimism. In this article, we are going to instrumentality a look astatine wherever 60 Degrees Pharmaceuticals, Inc. (NASDAQ:SXTP) stands against different stocks that autumn down amid marketplace optimism.

Wall Street’s main indices rebounded from hefty losses connected Wednesday aft President Donald Trump announced that the US volition intermission the imposition of higher tariffs connected 75 countries for 90 days.

In a station connected Truth Social, Trump said that much than 75 countries person called to negociate and person not retaliated successful immoderate way.

“I person authorized a 90-day PAUSE, and a substantially lowered Reciprocal Tariff during this period, of 10%, besides effectual immediately,” helium noted.

Following the announcement, the Dow Jones jumped by 7.87 percent, the S&P 500 surged by 9.52 percent, and the tech-heavy Nasdaq soared by 12.16 percent.

Despite the wide marketplace optimism, 10 companies, predominantly successful the biopharmaceutical sector, registered losses amid the deficiency of caller developments to spark buying appetite.

In this article, we listed Wednesday’s 10 worst performers and elaborate the reasons down their drop.

To travel up with the list, we considered lone the stocks with implicit $1 cardinal successful trading volume.

A chemist examining a beaker of colored liquid and precocious pharmaceuticals.

60 Degrees Pharmaceuticals saw its stock prices driblet by 12.89 percent connected Wednesday to extremity astatine $2.5 apiece aft earning a antagonistic standing from Weiss Ratings.

In its caller report, Weiss gave the institution a Sell standing connected the stock. The outlook followed HC Wainwright’s study past March 28 wherever it gave SXTP a Neutral rating.

In caller news, SXTP said it signed a patent licence statement with Yale School of Medicine and Yale School of Public Health to beforehand the improvement and commercialization of tafenoquine to dainty and forestall babesiosis.

Caused by Babesia, a microscopic parasite, the infectious illness spreads done black-legged ticks carried by deer. According to the company, it is peculiarly terrible successful the aged and those who are immunosuppressed.

According to SXTP, a randomized objective proceedings is underway to measure tafenoquine’s information and efficacy successful treating humans with terrible babesiosis.

Overall, SXTP ranks 6th connected our database of stocks that autumn down amid marketplace optimism. While we admit the imaginable of SXTP arsenic an investment, our condemnation lies successful the content that AI stocks clasp greater committedness for delivering higher returns and doing truthful wrong a shorter clip frame. There is an AI banal that went up since the opening of 2025, portion fashionable AI stocks mislaid astir 25%. If you are looking for an AI banal that is much promising than SXTP but that trades astatine little than 5 times its earnings, cheque retired our study astir this cheapest AI stock.